Published in Medicine and Law Weekly, July 28th, 2006
"Avidia's therapeutic discovery programs have advanced to a stage in which partnerships and licensing are expected to add to the sustained value growth of the company. Paulette has the right background and experience to help us capitalize on the external interest in our programs," said Peter Van Vlasselaer, PhD, Avidia's chief executive officer....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.